Experienced in Spontaneous Coronary Artery Dissection (SCAD)

Dr. Firas E. Zahr

Cardiology | Interventional Cardiology
University Professional Services
3181 Sw Sam Jackson Park Rd, 
Portland, OR 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Experienced in Spontaneous Coronary Artery Dissection (SCAD)
University Professional Services
3181 Sw Sam Jackson Park Rd, 
Portland, OR 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Firas Zahr is a Cardiologist and an Interventional Cardiologist in Portland, Oregon. Dr. Zahr is rated as an Experienced provider by MediFind in the treatment of Spontaneous Coronary Artery Dissection (SCAD). His top areas of expertise are Mitral Valve Regurgitation, Aortic Valve Stenosis, Tricuspid Regurgitation, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement. Dr. Zahr is currently accepting new patients.

His clinical research consists of co-authoring 122 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Spontaneous Coronary Artery Dissection (SCAD).

Specialties
Cardiology
Interventional Cardiology
Licenses
Internal Medicine in OH
Hospital Affiliations
Columbia Memorial Hospital
Ohsu Hospital And Clinics
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
BridgeSpan
  • EPO
  • HMO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Moda Health
  • EPO
  • PPO
PacificSource
  • PPO
Prominence Health
  • EPO
  • PPO
Regence
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

UNIVERSITY PROFESSIONAL SERVICES
3181 Sw Sam Jackson Park Rd, Portland, OR 97239

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO Trial
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO Trial
Enrollment Status: Recruiting
Publish Date: October 07, 2025
Intervention Type: Device
Study Phase: Not Applicable
Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device
Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device
Enrollment Status: Active_not_recruiting
Publish Date: October 09, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
Edwards PASCAL TrAnScatheter Valve RePair System in Tricuspid Regurgitation (CLASP TR) Early Feasibility Study
Edwards PASCAL TrAnScatheter Valve RePair System in Tricuspid Regurgitation (CLASP TR) Early Feasibility Study
Enrollment Status: Completed
Publish Date: September 29, 2025
Intervention Type: Device
Study Phase: Not Applicable
Early Feasibility Study Of the Edwards APTURE Transcatheter Shunt System (ALT-FLOW US)
Early Feasibility Study Of the Edwards APTURE Transcatheter Shunt System (ALT-FLOW US)
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2025
Intervention Type: Device
Study Phase: Not Applicable
Edwards EVOQUE Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy After Replacement of Tricuspid Valve With Transcatheter Device
Edwards EVOQUE Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy After Replacement of Tricuspid Valve With Transcatheter Device
Enrollment Status: Active_not_recruiting
Publish Date: August 15, 2025
Intervention Type: Device
Study Phase: Not Applicable
Transcatheter Aortic Valve Replacement (TAVR) With Medtronic TAVR System in Patients With Severe Bicuspid Aortic Valve Stenosis and at Low Predicted Risk of Mortality With Surgical Aortic Valve Replacement (SAVR)
Transcatheter Aortic Valve Replacement (TAVR) With Medtronic TAVR System in Patients With Severe Bicuspid Aortic Valve Stenosis and at Low Predicted Risk of Mortality With Surgical Aortic Valve Replacement (SAVR)
Enrollment Status: Active_not_recruiting
Publish Date: May 01, 2025
Intervention Type: Device
Study Phase: Not Applicable
Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
Enrollment Status: Active_not_recruiting
Publish Date: May 01, 2025
Intervention Type: Device
Study Phase: Not Applicable
Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance After Mitral Valve Replacement With Transcatheter Device (MISCEND)
Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance After Mitral Valve Replacement With Transcatheter Device (MISCEND)
Enrollment Status: Active_not_recruiting
Publish Date: November 27, 2024
Intervention Type: Device
Study Phase: Not Applicable
A U.S. Post-Approval Study of the SYNERGY 4.50/5.00 mm Everolimus-Eluting Platinum Chromium Coronary Stent System (Evolve 4.5/5.0)
A U.S. Post-Approval Study of the SYNERGY 4.50/5.00 mm Everolimus-Eluting Platinum Chromium Coronary Stent System (Evolve 4.5/5.0)
Enrollment Status: Completed
Publish Date: December 14, 2023
Intervention Type: Device
Annular ReduCtion for Transcatheter Treatment of Insufficient Mitral ValvE (ACTIVE): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Assess Transcatheter Mitral Valve Repair With Edwards Cardioband System and GDMT vs GDMT Alone in Patients With FMR and Heart Failure
Annular ReduCtion for Transcatheter Treatment of Insufficient Mitral ValvE (ACTIVE): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Assess Transcatheter Mitral Valve Repair With Edwards Cardioband System and GDMT vs GDMT Alone in Patients With FMR and Heart Failure
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Device
Study Phase: Not Applicable
A Clinical Evaluation of the Safety and Effectiveness of the MitraClip® System for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects (COAPT Recruitment Closed). COAPT CAS (Recruitment Closed)
A Clinical Evaluation of the Safety and Effectiveness of the MitraClip® System for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects (COAPT Recruitment Closed). COAPT CAS (Recruitment Closed)
Enrollment Status: Active_not_recruiting
Publish Date: November 27, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Heart Valve System in the Treatment of High Surgical Risk Patients With Symptomatic, Severe Aortic Regurgitation (AR)
A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Heart Valve System in the Treatment of High Surgical Risk Patients With Symptomatic, Severe Aortic Regurgitation (AR)
Enrollment Status: Active_not_recruiting
Publish Date: September 13, 2022
Intervention Type: Device
Study Phase: Not Applicable
View 11 Less Clinical Trials

122 Total Publications

Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial.
Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial.
Journal: European heart journal
Published: July 07, 2025
Similar Doctors
Elite in Spontaneous Coronary Artery Dissection (SCAD)
Dr. Lori M. Tam
Cardiology
Elite in Spontaneous Coronary Artery Dissection (SCAD)
Dr. Lori M. Tam
Cardiology
9427 Southwest Barnes Road, Suite 495, 
Portland, OR 
 (4.1 miles away)
503-962-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lori Tam is a Cardiologist in Portland, Oregon. Dr. Tam is rated as a Distinguished provider by MediFind in the treatment of Spontaneous Coronary Artery Dissection (SCAD). Her top areas of expertise are Spontaneous Coronary Artery Dissection (SCAD), Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Pulmonary Edema, and Pacemaker Implantation. Dr. Tam is currently accepting new patients.

Advanced in Spontaneous Coronary Artery Dissection (SCAD)
Dr. Sasidhar Guthikonda
Interventional Cardiology | Cardiology
Advanced in Spontaneous Coronary Artery Dissection (SCAD)
Dr. Sasidhar Guthikonda
Interventional Cardiology | Cardiology

Salem Health

890 Oak St Se, Suite 4000, 
Salem, OR 
 (42.6 miles away)
503-814-4048
Languages Spoken:
English, Arabic, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Sasidhar Guthikonda is an Interventional Cardiologist and a Cardiologist in Salem, Oregon. Dr. Guthikonda is rated as a Distinguished provider by MediFind in the treatment of Spontaneous Coronary Artery Dissection (SCAD). His top areas of expertise are Angina, Atherosclerosis, Coronary Heart Disease, and Heart Attack. Dr. Guthikonda is currently accepting new patients.

Experienced in Spontaneous Coronary Artery Dissection (SCAD)
Dr. David S. Peizner
Interventional Cardiology | Cardiology
Experienced in Spontaneous Coronary Artery Dissection (SCAD)
Dr. David S. Peizner
Interventional Cardiology | Cardiology

Legacy Good Samaritan Hospital And Medical Center

1015 Nw 22nd Ave, 
Portland, OR 
 (2.3 miles away)
503-413-7711
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Peizner is an Interventional Cardiologist and a Cardiologist in Portland, Oregon. Dr. Peizner is rated as an Advanced provider by MediFind in the treatment of Spontaneous Coronary Artery Dissection (SCAD). His top areas of expertise are Apoplexy, Heart Attack, Arterial Embolism, Angioplasty, and Heart Bypass Surgery. Dr. Peizner is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Zahr's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 26 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile